Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response
Authors:
Open Access
- 28 October 2022
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (11) , e24750
Abstract
Objective: Genetic variations can affect individual response to methadone maintenance treatment (MMT) for heroin addiction. The A118G variant (rs1799971) in the mu opioid receptor gene (OPRM1) is a potential candidate single nucleotide polymorphism (SNP) for personalized MMT. This study determined whether rs1799971 is related to MMT response or dose.Methods: We recruited 286 MMT patients from a Han Chinese population. The rs1799971 genotype was determined via TaqMan genotyping assay. The genetic effect of this SNP on MMT response or dose was evaluated using logistic regression. A meta‐analysis was performed to merge all available data to evaluate the role of rs1799971 in MMT using RevMan 5.3 software.Results: No statistical significance was observed in the association between the OPRM1 rs1799971 and MMT response or dose in our Chinese cohort. Meta‐analysis indicated that the OPRM1 A118G variation was not significantly associated with MMT response or dose requirement.Conclusion: The results suggest that rs1799971 in OPRM1 might not play a critical role alone in influencing MMT response or dose.Keywords
Funding Information
- National Natural Science Foundation of China (No.82071499)
This publication has 43 references indexed in Scilit:
- OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional studyJournal of Human Genetics, 2012
- Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patientsEuropean Neuropsychopharmacology, 2012
- ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsPharmacogenomics and Personalized Medicine, 2012
- β-Arrestin2 influences the response to methadone in opioid-dependent patientsThe Pharmacogenomics Journal, 2010
- Pharmacotherapy in the Treatment of Addiction: MethadoneJournal of Addictive Diseases, 2010
- A Meta-Analysis of Retention in Methadone Maintenance by Dose and Dosing StrategyThe American Journal of Drug and Alcohol Abuse, 2009
- Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Interindividual Variability of Methadone ResponseMolecular Diagnosis & Therapy, 2008
- Determining Effective Methadone Doses for Individual Opioid-Dependent PatientsPLOS Medicine, 2006
- Interindividual Variability of the Clinical Pharmacokinetics of MethadoneClinical Pharmacokinetics, 2002